Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (437)
Cancellation by sponsor (155)
Prescription medicine registration (28)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2025 (39)
2024 (47)
2023 (36)
2022 (54)
2021 (41)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

630 result(s) found, displaying 361 to 370

CELECOXIB RBX celecoxib 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
RANSIM simvastatin 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
RANSIM simvastatin 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
FRUSEMIDE RBX furosemide (frusemide) 40 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
FRUSEMIDE RBX furosemide (frusemide) 20 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
CLOPIDOGREL RBX clopidogrel (as hydrogen sulfate) 75 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
IRBESARTAN/HCTZ RBX 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
IRBESARTAN/HCTZ RBX 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
IRBESARTAN RBX irbesartan 150 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
IRBESARTAN RBX irbesartan 300 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 March 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd

Pages

First page
Previous page
…
Page 33
Page 34
Page 35
Page 36
Current page 37
Page 38
Page 39
Page 40
Page 41
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.